0.93
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
10.20%
9.617
|
8.7272 | 6.5232 | 9.3904 | 9.8946 |
Cost Of Revenue |
11.25%
2.803
|
2.5196 | -0.2479 | 4.1088 | 3.3919 |
Gross Profit |
9.77%
6.814
|
6.2076 | 6.7711 | 5.2816 | 6.5027 |
|
3.31%
10.43
|
10.09 | 10.82 | 9.6779 | 9.9216 |
Benefits Costs and Expenses |
100.00%
-
|
10.21 | 16.10 | 11.72 | 14.04 |
Costs And Expenses |
29.65%
13.23
|
10.21 | 16.10 | 11.72 | 14.04 |
Depreciation and Amortization |
9.77%
0.4045
|
0.3685 | 0.3894 | 0.3828 | 0.4006 |
Operating Income/Loss |
7.00%
-3.615
|
-3.8872 | -4.0454 | -4.3962 | -3.4188 |
Nonoperating Income/Loss |
130.90%
5.562
|
2.4089 | -5.5293 | 2.0622 | -0.7243 |
Income/Loss From Continuing Operations Before Tax |
750.52%
9.617
|
-1.4784 | -9.5747 | -2.3341 | -4.1431 |
Income Tax Expense/Benefit |
-
|
- | -1.6908 | - | - |
Income/Loss From Continuing Operations After Tax |
231.70%
1.947
|
-1.4784 | -7.8839 | -2.3341 | -4.1431 |
|
231.70%
1.947
|
-1.4784 | -7.8839 | -2.3341 | -4.1431 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3.09%
62.61
|
60.73 | 0.094 | 54.45 | 54.31 |
Diluted Average Shares |
10.59%
67.17
|
60.73 | 0.094 | 54.45 | 54.31 |
Basic Earnings Per Share |
250.00%
0.03
|
-0.02 | -0.14 | -0.05 | -0.08 |
Diluted Earnings Per Share |
250.00%
0.03
|
-0.02 | -0.14 | -0.05 | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):